Raykov Rosty's Form 4 filing
Fennec Pharmaceuticals Inc. (FENC) · filed Dec 5, 2024
- Accession no.
- 0001415889-24-028400
- Filed
- Dec 5, 2024
- Trade date
- Dec 5, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $4.81K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Raykov RostyCIK 0001468316 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | Common shares | SSaleDisposed | −796 | $6.04 | −$4,807.84 | 66,432 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.